News

The Commonwealth Fund9d
Medicare Drug Price Negotiations: All You Need to Know
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...
Health Affairs9d
Administration Releases Medicare Drug Price Negotiation Program Draft Guidance For 2028
The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...
Money Talks News on MSN1d
5.3 Million Medicare Users to Benefit From New Drug Price Negotiations
The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...
With the third round of Medicare price negotiations on the way, here’s how the policy is shifting
Medicare’s drug price negotiation program is progressing into its third round of selections, HHS announced last week. And as ...
US Medicare lays out timeline for third round of drug price negotiations
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...
JD Supra11d
Medicare Drug Price Negotiation Program: The Inflation Reduction Act “Pill Penalty” and Other IRA Reforms on the Horizon for 2026
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...
Truthout3d
Big Pharma Front Groups Muddle Debate Over Drug Prices, Patient Advocates Say
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
1BMY, JNJ : CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
National Law Review12d
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
Medicare to publish drugs selected for third round of price negotiations by Feb. 1
Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...
BioSpace11d
CMS Prepares for Third Cycle of Drug Negotiations as Trump Intensifies Push To Lower Prices
The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...